CRDF

Cardiff Oncology, Inc. CRDF

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,879 of 2,925

Why it scores 10Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$104.0K

Quarter to Jun 30

Net income

$-9.23M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$24.23M total
Laurion Capital Management LP
$4.03M+17.1%
VANGUARD CAPITAL MANAGEMENT LLC
$3.76M+1.4%
PFIZER INC
$3.01M0.0%
FRANKLIN RESOURCES INC
$1.57M0.0%
BlackRock, Inc.
$1.26M-75.6%
BLAIR WILLIAM & CO/IL
$1.19M-1.1%
GEODE CAPITAL MANAGEMENT, LLC
$1.07M-48.7%
UBS Group AG
$830.3K+59.4%
JANE STREET GROUP, LLC
$790.3K+1415.8%
VANGUARD FIDUCIARY TRUST CO
$533.8K-8.0%
AQR CAPITAL MANAGEMENT LLC
$450.3K+423.5%
STATE STREET CORP
$430.8K-72.1%
HRT FINANCIAL LP
$354.0KNew
FLPUTNAM INVESTMENT MANAGEMENT CO
$321.7K-58.4%
MORGAN STANLEY
$319.9K+337.1%
BNP PARIBAS FINANCIAL MARKETS
$297.0K+1647.2%
X-Square Capital, LLC
$267.0KNew
GSA CAPITAL PARTNERS LLP
$225.0K+40.9%
MARSHALL WACE, LLP
$210.9KNew
Bank of New York Mellon Corp
$210.2K-46.7%
NORTHERN TRUST CORP
$198.7K-69.0%
Avestar Capital, LLC
$177.0K0.0%
MILLENNIUM MANAGEMENT LLC
$174.9K+484.1%
Qube Research & Technologies Ltd
$163.2KNew
GOLDMAN SACHS GROUP INC
$157.1K-10.9%
See all 105 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CRDF

Earnings Per Share

13fpro.ai/company/CRDF

Loading ratio trend…

CRDF insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Cardiff Oncology, Inc. (CRDF): stock profile, AI score and financials

Cardiff Oncology, Inc. (CRDF) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CRDF at 9.5/100 on a composite quality score built from its SEC filings, placing it at rank #2,879 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Cardiff Oncology, Inc. reports quarterly revenue of $104.0K, net income of $-9.2M. Top institutional holders of CRDF by reported 13-F value include Laurion Capital Management, VANGUARD CAPITAL MANAGEMENT, PFIZER, based on the most recent SEC filings. CRDF trades on the Nasdaq exchange and files with the SEC under CIK 1213037. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CRDF daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardiff Oncology, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1213037 →